These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29248321)

  • 21. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
    deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detecting familial hypercholesterolaemia in general practice.
    Kirke A; Watts GF; Emery J
    Aust Fam Physician; 2012 Dec; 41(12):965-8. PubMed ID: 23210121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knowledge, awareness and practice regarding familial hypercholesterolaemia among primary care physicians in Malaysia: The importance of professional training.
    Azraii AB; Ramli AS; Ismail Z; Abdul-Razak S; Mohd-Kasim NA; Ali N; Watts GF; Nawawi H
    Atherosclerosis; 2018 Oct; 277():508-516. PubMed ID: 30270092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the "Ten Countries Study".
    Pang J; Hu M; Lin J; Miida T; Nawawi HM; Park JE; Wu X; Ramli AS; Kim NT; Kwok S; Gonzalez-Santos LE; Su TC; Truong TH; Soran H; Yamashita S; Tomlinson B; Watts GF
    BMJ Open; 2017 Oct; 7(10):e017817. PubMed ID: 29074516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis and treatment of familial hypercholesterolemia in Spain: Consensus document].
    Mata P; Alonso R; Ruiz A; Gonzalez-Juanatey JR; Badimón L; Díaz-Díaz JL; Muñoz MT; Muñiz O; Galve E; Irigoyen L; Fuentes-Jiménez F; Dalmau J; Pérez-Jiménez F
    Semergen; 2015; 41(1):24-33. PubMed ID: 25042971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical determinants and treatment gaps in familial hypercholesterolemia: Data from a multi-ethnic regional health service.
    Zafrir B; Jubran A; Lavie G; Halon DA; Flugelman MY; Shapira C
    Eur J Prev Cardiol; 2017 May; 24(8):867-875. PubMed ID: 28186442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial hypercholesterolaemia in primary care: knowledge and practices among general practitioners in Western Australia.
    Bell DA; Garton-Smith J; Vickery A; Kirke AB; Pang J; Bates TR; Watts GF
    Heart Lung Circ; 2014 Apr; 23(4):309-13. PubMed ID: 24054707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The extent of familial hypercholesterolemia instruction in US schools and colleges of medicine, pharmacy, and osteopathic medicine.
    Withycombe B; Winden JC; Hassanyn R; Duell PB; Ito MK
    J Clin Lipidol; 2015; 9(3):281-8. PubMed ID: 26073385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knowledge gaps in the management of familial hypercholesterolaemia. A UK based survey.
    Schofield J; Kwok S; France M; Capps N; Eatough R; Yadav R; Ray K; Soran H
    Atherosclerosis; 2016 Sep; 252():161-165. PubMed ID: 27451004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The very high cardiovascular risk in heterozygous familial hypercholesterolemia: Analysis of 734 French patients.
    Béliard S; Millier A; Carreau V; Carrié A; Moulin P; Fredenrich A; Farnier M; Luc G; Rosenbaum D; Toumi M; Bruckert E;
    J Clin Lipidol; 2016; 10(5):1129-1136.e3. PubMed ID: 27678429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients' attitudes toward detection of heterozygous familial hypercholesterolemia.
    Andersen LK; Jensen HK; Juul S; Faergeman O
    Arch Intern Med; 1997 Mar; 157(5):553-60. PubMed ID: 9066460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial hypercholesterolemia in childhood and adolescents: A hidden reality.
    Plana N; Rodríguez-Borjabad C; Ibarretxe D; Masana L
    Clin Investig Arterioscler; 2017; 29(3):129-140. PubMed ID: 28390853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dental screening and referral of young children by pediatric primary care providers.
    dela Cruz GG; Rozier RG; Slade G
    Pediatrics; 2004 Nov; 114(5):e642-52. PubMed ID: 15520094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive lipid and metabolite profiling of children with and without familial hypercholesterolemia: A cross-sectional study.
    Christensen JJ; Ulven SM; Retterstøl K; Narverud I; Bogsrud MP; Henriksen T; Bollerslev J; Halvorsen B; Aukrust P; Holven KB
    Atherosclerosis; 2017 Nov; 266():48-57. PubMed ID: 28963918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization.
    Descamps OS; Tenoutasse S; Stephenne X; Gies I; Beauloye V; Lebrethon MC; De Beaufort C; De Waele K; Scheen A; Rietzschel E; Mangano A; Panier JP; Ducobu J; Langlois M; Balligand JL; Legat P; Blaton V; Muls E; Van Gaal L; Sokal E; Rooman R; Carpentier Y; De Backer G; Heller FR
    Atherosclerosis; 2011 Oct; 218(2):272-80. PubMed ID: 21762914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric implications of heterozygous familial hypercholesterolemia. Screening and dietary treatment.
    Kwiterovich PO
    Arteriosclerosis; 1989; 9(1 Suppl):I111-20. PubMed ID: 2563219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry.
    Ahmad ZS; Andersen RL; Andersen LH; O'Brien EC; Kindt I; Shrader P; Vasandani C; Newman CB; deGoma EM; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Kullo IJ; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    J Clin Lipidol; 2016; 10(5):1223-9. PubMed ID: 27678440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial hypercholesterolemia in children and adolescents: A clinical perspective.
    de Ferranti SD
    J Clin Lipidol; 2015; 9(5 Suppl):S11-9. PubMed ID: 26343208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ambulatory pediatricians: how to bridge the gaps in diagnosis and care coordination for neurodevelopmental disorders in France.
    Willig TN; Blanc JP; Assathiany R; Bilbault C; Raffier L; Werner A
    Front Pediatr; 2024; 12():1269198. PubMed ID: 38725981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cascade screening for familial hypercholesterolemia: Practical consequences.
    Louter L; Defesche J; Roeters van Lennep J
    Atheroscler Suppl; 2017 Nov; 30():77-85. PubMed ID: 29096865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.